Skip to main content
OpenTrials
Completed

NCT Number: NCT06535698

Evaluating the Effect of a Supplement on Symptoms of Hormonal Imbalance.

This is a virtual single-group trial lasting 12 weeks to evaluate the effects of Perelel Health's hormonal balance support on symptoms of hormonal imbalance and overall menstrual health.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Women's Health

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Santa Monica, California, 90404, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Self-reported symptoms of hormonal imbalance (e.g., mood swings, irregular menstrual cycles)
  • Generally healthy without uncontrolled chronic diseases
  • Willing to avoid new hormonal balance treatments during the study
  • Consistent use of current hormonal balance treatments for at least 3 months prior to the study

Exclusion criteria

  • Chronic conditions preventing adherence to the protocol Diabetes
  • Planned hormonal balance-related procedures during the study
  • Started any new medications or supplements that target hormonal balance in the past 3 months
  • Anyone with diabetes
  • Severe allergies requiring EpiPen
  • Pregnant, breastfeeding, or trying to conceive
  • Recent surgeries or planned surgeries during the study
  • Unwilling to follow the study protocol

Treatment and study plan

Perelel Health Hormonal Balance Support

Dietary Supplement

The supplement contains Myo-inositol (1000 mcg), Metabolic balance blend (200 mcg) including Berberine HCl, Alpha lipoic acid, DIM (33'-Diindolylmethane), and D-chiro-inositol (25 mg). Other ingredients include Vegetable cellulose (capsule), plant cellulose, and L-leucine.

Primary outcomes

  1. Changes in Symptoms of Hormonal Imbalance

    Time frame: Baseline, Week 4, Week 8, Week 12

    Evaluation of the effect of Perelel Health hormonal balance support on symptoms of hormonal imbalance using a self-reported questionnaire.

Secondary outcomes

  1. Changes in Overall Menstrual Health

    Time frame: Baseline, Week 4, Week 8, Week 12

    Assessment of the impact of Perelel Health hormonal balance support on menstrual health using a self-reported questionnaire.

Sponsors and collaborators

Lead sponsor

Perelel Inc.

Industry

Collaborators

  • Citruslabs

Registry information

Official study title

A Single-Group Clinical Trial to Evaluate the Effect of an Oral Supplement to Provide Relief From Symptoms of Hormonal Imbalance.

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Aug 2, 2024
Registry last updated
Aug 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.